Vanguard Group’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.4M | Sell |
|
|||||
|
2025
Q1 | $18.6M | Buy |
|
|||||
|
2024
Q4 | $30M | Sell |
|
|||||
|
2024
Q3 | $33.4M | Buy |
|
|||||
|
2024
Q2 | $28.3M | Buy |
|
|||||
|
2024
Q1 | $35.3M | Buy |
|
|||||
|
2023
Q4 | $9.14M | Buy |
|
|||||
|
2023
Q3 | $11.5M | Buy |
|
|||||
|
2023
Q2 | $7.61M | Sell |
|
|||||
|
2023
Q1 | $7.71M | Hold |
|
|||||
|
2022
Q4 | $4.63M | Buy |
|
|||||
|
2022
Q3 | $4.35M | Buy |
|
|||||
|
2022
Q2 | $5.69M | Sell |
|
|||||
|
2022
Q1 | $14.1M | Buy |
|
|||||
|
2021
Q4 | $15.2M | Buy |
|
|||||
|
2021
Q3 | $23.6M | Sell |
|
|||||
|
2021
Q2 | $22.6M | Sell |
|
|||||
|
2021
Q1 | $16.9M | Buy |
|
|||||
|
2020
Q4 | $20.9M | Sell |
|
|||||
|
2020
Q3 | $26.2M | Sell |
|
|||||
|
2020
Q2 | $15.8M | Sell |
|
|||||
|
2020
Q1 | $11.3M | Buy |
|
|||||
|
2019
Q4 | $15.3M | Buy |
|
|||||
|
2019
Q3 | $20.4M | Buy |
|
|||||
|
2019
Q2 | $46.2M | Buy |
|
|||||
|
2019
Q1 | $27.1M | Buy |
|
|||||
|
2018
Q4 | $15.5M | Buy |
|
|||||
|
2018
Q3 | $10.6M | Buy |
|
|||||
|
2018
Q2 | $7.68M | Sell |
|
|||||
|
2018
Q1 | $7.81M | Buy |
|
|||||
|
2017
Q4 | $7.8M | Buy |
|
|||||
|
2017
Q3 | $5.98M | Buy |
|
|||||
|
2017
Q2 | $2.63M | Sell |
|
|||||
|
2017
Q1 | $6.72M | Buy |
|
|||||
|
2016
Q4 | $8.46M | Buy |
|
|||||
|
2016
Q3 | $9.07M | Buy |
|
|||||
|
2016
Q2 | $9.78M | Buy |
|
|||||
|
2016
Q1 | $8.54M | Buy |
|
|||||
|
2015
Q4 | $10.6M | Sell |
|
|||||
|
2015
Q3 | $8.09M | Buy |
|
|||||
|
2015
Q2 | $23.6M | Buy |
|
|||||
|
2015
Q1 | $39.9M | Buy |
|
|||||
|
2014
Q4 | $30.1M | Buy |
|
|||||
|
2014
Q3 | $20.9M | Buy |
|
|||||
|
2014
Q2 | $24.9M | Buy |
|
|||||
|
2014
Q1 | $35.3M | Buy |
|
|||||
|
2013
Q4 | $26M | Buy |
|
|||||
|
2013
Q3 | $12.6M | Buy |
|
|||||
|
2013
Q2 | $9.18M | Buy |
|